Driving Breakthroughs in Healthcare, One Bold Idea at a Time

Featured

Fusion: Origin to $2.4 Billion USD

Latest

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

06 December 2024

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

02 December 2024

Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025

04 November 2024

All Articles

04 September 2024

Feldan Therapeutics Completes a US$ 21 Million Series B financing co-led by Genesys Capital and Fonds de Solidarité Ftq

Two Genesys co-creations listed on Fierce's Top 10 smartest deals in biopharma

Fusion: Origin to $2.4 Billion USD

Inversago: Origin to $1.4 Billion USD